MedTrace Logo

Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China

NCT02638077 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2015-12-22

No results posted yet for this study

Summary

* To find out the gap between real-world clinical practice and guideline recommendations in initial management of DTC patients
* To observe the characteristics of patients who achieved and did not achieve TSH target value after one year follow-up
* To assess response to initial therapy in patients who undergo total or near-total thyroidectomy and RAI remnant ablation after one year follow-up (according to an modified dynamic risk stratification system)
* To observe the recurrence status after one year follow-up

Conditions

  • Differentiated Thyroid Cancer

Sponsors & Collaborators

  • West China Hospital

    collaborator OTHER

  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • Jilin University

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Gansu Cancer Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • First Hospital of China Medical University

    collaborator OTHER

  • Huazhong University of Science and Technology

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02638077 on ClinicalTrials.gov